Oral contraceptives and coronary heart disease: Modulation of glucose tolerance and plasma lipid risk factors by progestins
- 1 June 1988
- journal article
- review article
- Published by Elsevier in American Journal of Obstetrics and Gynecology
- Vol. 158 (6) , 1612-1620
- https://doi.org/10.1016/0002-9378(88)90199-8
Abstract
No abstract availableKeywords
This publication has 69 references indexed in Scilit:
- Sex, plasma lipoproteins, and atherosclerosis: Prevailing assumptions and outstanding questionsAmerican Heart Journal, 1987
- Metabolic risk factors for coronary heart disease in women: Perspective from the Framingham StudyAmerican Heart Journal, 1987
- Oral glucose tolerance and the potency of contraceptive progestinsJournal of Chronic Diseases, 1985
- Effect of Estrogen/Progestin Potency on Lipid/Lipoprotein CholesterolNew England Journal of Medicine, 1983
- Oral Contraceptives and Cardiovascular DiseaseNew England Journal of Medicine, 1981
- Glucose tolerance and coronary heart disease: Helsinki Policemen StudyJournal of Chronic Diseases, 1979
- Serum High-Density-Lipoprotein Cholesterol in Women Using Oral Contraceptives, Estrogens and ProgestinsNew England Journal of Medicine, 1978
- HDL cholesterol and other lipids in coronary heart disease. The cooperative lipoprotein phenotyping study.Circulation, 1977
- Ischemic Heart Disease, Atherosclerosis, and LongevityCirculation, 1966
- Effect of posture on the plasma cholesterol level.BMJ, 1966